In this episode, Darrell H. S. Tan, MD, FRCPC, PhD, and Kenric Ware, PharmD, AAHIVP, discuss considerations for HIV pre-exposure prophylaxis (PrEP) persistence, including:The PrEP continuum of care in the United States, including inequities in PrEP uptake and persistence by raceCDC PrEP guidance regarding PrEP indicationsPrEP eligibility by regimenSummary of renal, bone, and weight outcomes with different PrEP optionsData on HIV acquisition following PrEP discontinuationDrug concentrations and recommendations for stopping long-acting cabotegravir for PrEPExpanding PrEP options to facilitate adherence and persistenceProviding PrEP by telehealthPresenters:Darrell H. S. Tan, MD, FRCPC, PhDAssociate ProfessorDivision of Infectious DiseasesUniversity of TorontoClinician-ScientistDivision of Infectious DiseasesSt. Michael’s HospitalToronto, CanadaKenric Ware, PharmD, AAHIVPAssociate ProfessorDepartment of Pharmacy PracticeSouth UniversitySavannah, GeorgiaChairperson, PharmacistBoard of DirectorsJoseph H. Neal Health CollaborativeColumbia, South CarolinaLink to full program:https://bit.ly/3HPu4Lk Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related